Chemical structure of flavoxate

Find information on thousands of medical conditions and prescription drugs.

Flavoxate

Flavoxate is an anticholinergic with antimuscarinic effects. Its muscle relaxant properties may be due to a direct action on the smooth muscle rather than by antagonizing muscarinic receptors. more...

A

B

C

D

E

F

Fludrocortisone

Fluorometholone

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Clinical uses

Flavoxate is used to treat urinary bladder spasms. It is available under the trade name Urispas (Paladin).

Sources

Brenner, G. M. (2000). Pharmacology. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6
Canadian Pharmacists Association (2000). Compendium of Pharmaceuticals and Specialties (25th ed.). Toronto, ON: Webcom. ISBN 0-919115-76-4

Read more at Wikipedia.org

• [List your site here Free!]



	Bladder infection Bladder infection, also called cystitis, refers to infection and inflammation of the urinary bladder. Urethritis is an inflammation of the urethra, which ... From Gale Encyclopedia of Alternative Medicine, 4/6/01 by Belinda Rowland

	Cystitis Cystitis is defined as inflammation of the urinary bladder. Urethritis is an inflammation of the urethra, which is the passageway that connects the bladder ... From Gale Encyclopedia of Medicine, 4/6/01 by Rebecca J. Frey

	Pilocarpine Definition Pilocarpine is a medicine used to treat xerostomia, or dryness of the mouth, caused by a decrease in saliva production following ... From Gale Encyclopedia of Cancer, by M.Sc. Racquel Baert

	Incontinence comes out of the closet Incontinence Comes Out of the Closet Unless 9-year-old Linda is wakened for a trip to the bathroom several times a night, she wets the bed. She's afraid ... From FDA Consumer, 3/1/87 by Dixie Farley

	Nonpharmacologic treatment of urinary incontinence Standard therapy for urinary incontinence often includes pharmaceutical agents that carry a risk of side effects or interactions with other drugs. As ... From American Family Physician, 8/1/91 by Barry D. Weiss

	IMPAX Reports Third Quarter 2004 Financial Results HAYWARD, Calif. -- Company to Restate First and Second Quarter 2004 Results Due to Reporting Adjustments on Bupropion Revenues by Strategic Partner IMPAX Laboratories, Inc. (NASDAQ:IPXL) today re From Business Wire, 11/9/04

	IMPAX Reports Fourth Quarter and 2003 Financial Results; Received 9 FDA Approvals; Filed 8 Applications in Year Business Editors/Health/Medical Writers HAYWARD, Calif.--(BUSINESS WIRE)--Feb. 17, 2004 IMPAX Laboratories, Inc. (Nasdaq:IPXL) today reported financial ... From Business Wire, 2/17/04

	IMPAX Receives FDA Approval for Generic Urispas Business Editors/Health/Medical Writers HAYWARD, Calif.--(BUSINESS WIRE)--Aug. 29, 2003 IMPAX Laboratories, Inc. (Nasdaq:IPXL) today announced that ... From Business Wire, 8/29/03

Home

Contact

Resources

ebay